MedPath

Impact of an 8-week Linoleic Acid Intake in Soy Oil on Lp-PLA2 Activity in Healthy Adults

Phase 3
Completed
Conditions
Healthy Subjects
Interventions
Dietary Supplement: Low LA
Dietary Supplement: High LA
Registration Number
NCT02753907
Lead Sponsor
Yonsei University
Brief Summary

Self-reported healthy participants (n=150) aged 30-65 years with 18.5 kg/m\^2 ≤ BMI \< 30 kg/m\^2 were randomly assigned into three groups: a low linoleic acid (LA, 18:2n-6) group (n=50) replaced 10 mL soy oil with one apple; a medium LA group (control group, n=50) maintained usual food intake; a high LA group (n=50) reduced 1/3 cup of cooked refined rice and consumed 9.9g of soy oil capsules daily as a supplement. Plasma fatty acids and lipoprotein-associated phospholipase A2 (Lp-PLA2) activity were measured at baseline and 8 week alongside other cardiovascular disease risk factors.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Age 30 to 65 years at beginning of study
  • Subjects with BMI 18.5 to 30 kg/m^2
Read More
Exclusion Criteria
  • Use of any medication or supplements that alter lipid metabolism.
  • Presence of dyslipidemia, diabetes mellitus, hypertension, liver disease, renal disease, chronic disease of the gastrointestinal tract, cerebrovascular disease, pancreatitis or cancer.
  • Women who pregnant or lactating.
  • Drug or alcohol abuse.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Low LA (linoleic acid)Low LAIndividuals who replaced 10 mL soy oil with one apple
High LAHigh LAIndividuals who reduced 1/3 cup of cooked refined rice and consumed 9.9 g of soy oil as a supplement
Primary Outcome Measures
NameTimeMethod
Change in Lp-PLA2 activity (nmol/mL/min)At baseline and end of each 8-week diet period
Secondary Outcome Measures
NameTimeMethod
Change in LDL cholesterol (mg/dL)At baseline and end of each 8-week diet period

Lipids and lipoproteins, such as total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, Apo A-I, Apo B

Change in HDL cholesterol (mg/dL)At baseline and end of each 8-week diet period
Change in triglyceride (mg/dL)At baseline and end of each 8-week diet period
Change in total cholesterol (mg/dL)At baseline and end of each 8-week diet period

Trial Locations

Locations (1)

Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University.

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath